Published in Anticancer Res on August 01, 2012
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol (2005) 3.15
Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol (2004) 3.06
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol (2009) 2.41
Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma. Eur Urol (2008) 2.37
Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol (2007) 2.30
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival. Eur Urol (2006) 2.15
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study. Cancer (2005) 2.15
Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol (2007) 2.09
Prognostic value of thrombocytosis in renal cell carcinoma. J Urol (2006) 1.87
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population. Eur Urol (2011) 1.87
Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma. J Urol (2009) 1.83
A preoperative prognostic model for patients treated with nephrectomy for renal cell carcinoma. Eur Urol (2008) 1.77
Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol (2007) 1.67
Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration. Am J Ophthalmol (2005) 1.59
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol (2004) 1.52
Platelet count and preoperative haemoglobin do not significantly increase the performance of established predictors of renal cell carcinoma-specific mortality. Eur Urol (2007) 1.51
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients. Cancer (2007) 1.43
Frozen Sections in Pleural Pathology: A Valuable Tool. Respiration (2017) 1.39
Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol (2006) 1.27
Serum miR-210 as a novel biomarker for molecular diagnosis of clear cell renal cell carcinoma. Exp Mol Pathol (2012) 1.23
Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies. J Pharm Biomed Anal (2011) 1.21
Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int (2007) 1.19
Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment. Eur J Cancer (2010) 1.13
Prognostic ability of simplified nuclear grading of renal cell carcinoma. Cancer (2007) 1.11
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. BJU Int (2010) 1.10
Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the French randomised trial ACCORD12/0405 PRODIGE 2. Eur J Cancer (2012) 1.10
Revisited microanatomy of the corneal endothelial periphery: new evidence for continuous centripetal migration of endothelial cells in humans. Stem Cells (2012) 1.08
Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol (2007) 1.08
Macrophages from cancer patients: analysis of TRAIL, TRAIL receptors, and colon tumor cell apoptosis. J Natl Cancer Inst (2003) 1.07
Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol (2007) 1.06
Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions. Clin Cancer Res (2005) 1.06
True aneurysms of the pancreaticoduodenal artery: successful non-operative management. Surgery (2006) 1.05
Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol (2008) 1.05
Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles. Biomaterials (2012) 1.04
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy. Can Urol Assoc J (2008) 1.03
Impact of the primary Gleason pattern on biochemical recurrence-free survival after radical prostatectomy: a single-center cohort of 1,248 patients with Gleason 7 tumors. World J Urol (2010) 1.03
Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol (2009) 1.02
Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review. J Pediatr Urol (2009) 1.02
Prolonged survival of Fischer rats bearing F98 glioma after iodine-enhanced synchrotron stereotactic radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.01
Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. Cryobiology (2005) 1.01
Unclassified renal cell carcinoma: an analysis of 85 cases. BJU Int (2007) 0.98
Multi-institutional validation of a symptom based classification for renal cell carcinoma. J Urol (2004) 0.98
Prognostic relevance of tumour size in T3a renal cell carcinoma: a multicentre experience. Eur Urol (2007) 0.98
Chromophobe renal cell carcinoma: comprehensive analysis of 104 cases from multicenter European database. Urology (2005) 0.97
Prostate cancer in renal transplant recipients. Nephrol Dial Transplant (2008) 0.95
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy. Cancer (2008) 0.94
Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients. Int J Cancer (2011) 0.93
Prolonged temozolomide for treatment of glioblastoma: preliminary clinical results and prognostic value of p53 overexpression. J Neurooncol (2011) 0.93
A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients. J Urol (2007) 0.92
Accuracy and feasibility of electromagnetic navigated bronchoscopy under nitrous oxide sedation for pulmonary peripheral opacities: an outpatient study. Respiration (2009) 0.91
Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome. Clin Rheumatol (2004) 0.91
Spontaneous splenic rupture in primary cytomegalovirus infection. Presse Med (2007) 0.90
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol (2009) 0.89
Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma. Eur Urol (2010) 0.89
Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma. BJU Int (2008) 0.89
Implementation of molecular intra-operative assessment of sentinel lymph node in breast cancer. Anticancer Res (2011) 0.88
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma. Cancer (2005) 0.88
Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors. J Urol (2004) 0.88
In vivo cryochemotherapy of a human lung cancer model. Cryobiology (2005) 0.87
Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy. BJU Int (2009) 0.87
Plastinated nasal model: a new concept of anatomically realistic cast. Rhinology (2011) 0.87
Tumor size improves the accuracy of TNM predictions in patients with renal cancer. Eur Urol (2006) 0.87
[Complications and medium-term functional results of TVT in stress urinary incontinence]. Prog Urol (2003) 0.86
Benefit of a combined treatment of cryotherapy and chemotherapy on tumour growth and late cryo-induced angiogenesis in a non-small-cell lung cancer model. Lung Cancer (2006) 0.86
[Varicocele and male infertility: AFU 2006 guidelines]. Prog Urol (2007) 0.86
Tissue compartment analysis for biomarker discovery by gene expression profiling. PLoS One (2009) 0.85
CA9 as a molecular marker for differential diagnosis of cystic renal tumors. Urol Oncol (2010) 0.85
Different DNA ploidy patterns for the differentiation of common subtypes of renal tumors. Cell Oncol (2005) 0.85
Testosterone Deficiency Syndrome (TDS) needs to be named appropriately--the importance of accurate terminology. Eur Urol (2006) 0.85
Elevated serum-circulating RNA in patients with conventional renal cell cancer. Anticancer Res (2008) 0.85
Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia. Virchows Arch (2005) 0.85
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram. Int J Cancer (2007) 0.85
Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics. Urology (2009) 0.84
Malleus head fixation: histopathology revisited. Acta Otolaryngol (2006) 0.84
[Superficial angiomyxoma: report of four cases, including two subungueal tumors]. Ann Pathol (2005) 0.84
Optimization of immunolocalization of cell cycle proteins in human corneal endothelial cells. Mol Vis (2011) 0.84
ECOG performance status 0 or 1 and symptom classification do not improve the ability to predict renal cell carcinoma-specific survival. Eur J Cancer (2007) 0.84
Prognostic variables to predict cancer-related death in incidental renal tumours. BJU Int (2008) 0.84
Use of poloxamers for deswelling of organ-cultured corneas. Invest Ophthalmol Vis Sci (2008) 0.84
Testicular sperm extraction in a single cancerous testicle in patients with azoospermia: a case report. Fertil Steril (2007) 0.84
Impact of acoustic airflow nebulization on intrasinus drug deposition of a human plastinated nasal cast: new insights into the mechanisms involved. Int J Pharm (2011) 0.84
Conventional liquid-based techniques versus Cytyc Thinprep processing of urinary samples: a qualitative approach. BMC Clin Pathol (2005) 0.83
Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int (2008) 0.83
Impact of airborne particle size, acoustic airflow and breathing pattern on delivery of nebulized antibiotic into the maxillary sinuses using a realistic human nasal replica. Pharm Res (2014) 0.83
The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Eur Urol (2005) 0.82
Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer (2005) 0.82
Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma. Histol Histopathol (2013) 0.82
Comparison of UW and Celsior: long-term results in kidney transplantation. Ann Transplant (2013) 0.81
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram. BJU Int (2007) 0.81
Cadherin-6 gene expression in conventional renal cell carcinoma: a useful marker to detect circulating tumor cells. Anticancer Res (2005) 0.81
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma. BJU Int (2008) 0.81